Related Experiment Video
Updated: Jan 23, 2026

Production and Detection of Reactive Oxygen Species ROS in Cancers
Published on: November 21, 2011
ROS-Mediated Cancer Cell Killing through Dietary Phytochemicals
Saranya NavaneethaKrishnan1, Jesusa L Rosales1, Ki-Young Lee1
1Department of Cell Biology and Anatomy, and Arnie Charbonneau Cancer and Alberta Children's Hospital Research Institutes, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada T2N 4N1.
Abstract:
Reactive oxygen species (ROS) promote carcinogenesis by inducing genetic mutations, activating oncogenes, and raising oxidative stress, which all influence cell proliferation, survival, and apoptosis. Cancer cells display redox imbalance due to increased ROS level compared to normal cells. This unique feature in cancer cells may, therefore, be exploited for targeted therapy. Over the past few decades, natural compounds have attracted attention as potential cancer therapies because of their ability to maintain cellular redox homeostasis with minimal toxicity. Preclinical studies show that bioactive dietary polyphenols exert antitumor effects by inducing ROS-mediated cytotoxicity in cancer cells. These bioactive compounds also regulate cell proliferation, survival, and apoptotic and antiapoptotic signalling pathways. In this review, we discuss (i) how ROS is generated and (ii) regulated and (iii) the cell signalling pathways affected by ROS. We also discuss (iv) the various dietary phytochemicals that have been implicated to have cancer therapeutic effects through their ROS-related functions.
Insights
Reactive oxygen species (ROS) drive cancer by damaging DNA and altering cell signals. Dietary polyphenols show promise in cancer therapy by targeting cancer cells
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Reactive oxygen species (ROS) are crucial in carcinogenesis, inducing genetic mutations and oxidative stress that affect cell proliferation, survival, and apoptosis.
- Cancer cells exhibit a redox imbalance with elevated ROS levels compared to normal cells, presenting a therapeutic vulnerability.
- Natural compounds, particularly dietary polyphenols, are investigated for cancer therapy due to their ability to restore redox homeostasis with low toxicity.
Purpose of the Study:
- To review the generation, regulation, and signaling pathways of ROS in cancer.
- To explore the therapeutic potential of dietary phytochemicals targeting ROS in cancer treatment.
Main Methods:
- Literature review of ROS generation, regulation, and signaling in cancer.
- Analysis of preclinical studies on dietary phytochemicals and their ROS-related anticancer effects.
Main Results:
- ROS play a dual role in cancer, promoting initiation and progression but also offering a target for therapy.
- Dietary polyphenols demonstrate antitumor effects by inducing ROS-mediated cytotoxicity in cancer cells.
- These compounds modulate key cell signaling pathways involved in proliferation, survival, and apoptosis.
Conclusions:
- The unique redox imbalance in cancer cells can be exploited for targeted therapies.
- Dietary phytochemicals represent a promising avenue for developing novel cancer treatments by modulating ROS.
- Further research into ROS-related functions of phytochemicals may lead to effective cancer therapeutics.
Related Concept Videos
Dietary Connections
Proteins: Dietary Sources and Requirements
Carbohydrates: Dietary Sources and Requirements
Lipids: Dietary Sources and Requirements
Receptor-mediated Endocytosis
Cell-mediated Immune Responses

